Fenoy, Albert J. http://orcid.org/0000-0002-9554-9885
Schulz, Paul E. http://orcid.org/0000-0003-0676-002X
Sanches, Marsal http://orcid.org/0000-0002-6993-6822
Selvaraj, Sudhakar http://orcid.org/0000-0002-9494-172X
Burrows, Christina L.
Asir, Bashar
Conner, Christopher R.
Quevedo, Joao
Soares, Jair C. http://orcid.org/0000-0002-5466-5628
Article History
Received: 20 November 2021
Revised: 11 February 2022
Accepted: 22 February 2022
First Online: 14 March 2022
Competing interests
: AJF serves as a consultant for Medtronic, Inc and receives grant support from the NIH/NINDS (1R01NS113893-01A1). PES is a consultant for Lilly, Acadia, and Biogen, has grant support from the Weston Brain Foundation, the Frontotemporal Disease association, and the Kleberg Foundation, and has NIH support on unrelated projects. SS has received grants/research support from NIH/NIMH (1R21MH119441-01A1) and SAMHSA (6H79FG000470-01M003); research support from Compass Pathways, LivaNova, Janssen; speaking honoraria from the British Medical Journal Publishing Group and copyright with Cambridge University Press. JQ receives research support from the NIH/NIMH (1R21MH117636-01A1), the Faillace Department of Psychiatry and Behavioral Sciences, and LivaNova; has speaker bureau membership with Myriad Neuroscience, Janssen Pharmaceuticals, and Abbvie; is consultant for Eurofarma; is stockholder at Instituto de Neurociencias Dr. Joao Quevedo; and receives copyrights from Artmed Editora, Artmed Panamericana, and Elsevier/Academic Press. JCS receives grant/research support from Bristol-Meyers Squibb, Forest Laboratories, Merck and Elan Pharmaceuticals, and serves as a consultant for Pfizer, Abbot, and Astellas Pharma, Inc. MS, CRC, and CLB reported no biomedical financial interests or potential conflicts of interest.